1. Product Overview
2. Research Methodology
3. Executive Summary
4. Impact of COVID-19
on Global Peripheral Blood Mononuclear Cells Market
5. Voice of Customer
5.1. By Type of Product
5.2. By Type of Technique
5.3. Type of Application
for Which PBMCs Are Used
5.4. Factors Driving
Market Growth
6.
Global Peripheral Blood Mononuclear Cells Market Outlook
6.1. Market Size &
Forecast
6.1.1. By Value
6.2. Market Share &
Forecast
6.2.1. By Product (Cryopreserved or Frozen PBMC, Cultured or
Fresh PBMC and Peripheral Blood Mononuclear Cell Isolation & Viability
Kits)
6.2.2. By Application (Immunology, Infectious Disease,
Hematology and Others)
6.2.3. By Technique (Density Gradient Centrifugation Process and
Leukapheresis)
6.2.4. By Source (Human and Animals)
6.2.5. By Region (North America, Europe, Asia Pacific, South
America, Middle East & Africa)
6.2.6. By Company (2021)
6.3. Market Map
6.3.1. By Product
6.3.2. By Application
6.3.3. By Technique
6.3.4. By Source
6.3.5. By Region
7.
North America Peripheral Blood Mononuclear Cells Market
Outlook
7.1. Market Size &
Forecast
7.1.1. By Value
7.2. Market Share &
Forecast
7.2.1.
By
Product
7.2.2. By Application
7.2.3. By Technique
7.2.4. By Source
7.2.5. By Country
7.3. North America:
Country Analysis
7.3.1. United States
Peripheral Blood Mononuclear Cells Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Product
7.3.1.2.2.
By Application
7.3.1.2.3.
By Technique
7.3.1.2.4.
By Source
7.3.2. Canada Peripheral
Blood Mononuclear Cells Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Product
7.3.2.2.2.
By Application
7.3.2.2.3.
By Technique
7.3.2.2.4.
By Source
7.3.3. Mexico Peripheral
Blood Mononuclear Cells Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Product
7.3.3.2.2.
By Application
7.3.3.2.3.
By Technique
7.3.3.2.4.
By Source
8.
Europe Peripheral Blood Mononuclear Cells Market Outlook
8.1. Market Size &
Forecast
8.1.1. By Value
8.2. Market Share &
Forecast
8.2.1.
By
Product
8.2.2.
By
Application
8.2.3.
By Technique
8.2.4.
By Source
8.2.5. By Country
8.3. Europe: Country
Analysis
8.3.1. Germany Peripheral
Blood Mononuclear Cells Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Product
8.3.1.2.2.
By Application
8.3.1.2.3.
By Technique
8.3.1.2.4.
By Source
8.3.2. France Peripheral
Blood Mononuclear Cells Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Product
8.3.2.2.2.
By Application
8.3.2.2.3.
By Technique
8.3.2.2.4.
By Source
8.3.3. United Kingdom
Peripheral Blood Mononuclear Cells Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Product
8.3.3.2.2.
By Application
8.3.3.2.3.
By Technique
8.3.3.2.4.
By Source
8.3.4. Italy Peripheral
Blood Mononuclear Cells Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Product
8.3.4.2.2.
By Application
8.3.4.2.3.
By Technique
8.3.4.2.4.
By Source
8.3.5. Spain Peripheral
Blood Mononuclear Cells Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Product
8.3.5.2.2.
By Application
8.3.5.2.3.
By Technique
8.3.5.2.4.
By Source
9.
Asia-Pacific Peripheral Blood Mononuclear Cells Market
Outlook
9.1. Market Size &
Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1.
By
Product
9.2.2.
By
Application
9.2.3.
By
Technique
9.2.4.
By Source
9.2.5. By Country
9.3. Asia-Pacific:
Country Analysis
9.3.1. China Peripheral
Blood Mononuclear Cells Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Product
9.3.1.2.2.
By Application
9.3.1.2.3.
By Technique
9.3.1.2.4.
By Source
9.3.2. Japan Peripheral
Blood Mononuclear Cells Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Product
9.3.2.2.2.
By Application
9.3.2.2.3.
By Technique
9.3.2.2.4.
By Source
9.3.3. India Peripheral
Blood Mononuclear Cells Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Product
9.3.3.2.2.
By Application
9.3.3.2.3.
By Technique
9.3.3.2.4.
By Source
9.3.4. South Korea
Peripheral Blood Mononuclear Cells Market Outlook
9.3.4.1.
Market Size & Forecast
9.3.4.1.1.
By Value
9.3.4.2.
Market Share & Forecast
9.3.4.2.1.
By Product
9.3.4.2.2.
By Application
9.3.4.2.3.
By Technique
9.3.4.2.4.
By Source
9.3.5. Australia Peripheral
Blood Mononuclear Cells Market Outlook
9.3.5.1.
Market Size & Forecast
9.3.5.1.1.
By Value
9.3.5.2.
Market Share & Forecast
9.3.5.2.1.
By Product
9.3.5.2.2.
By Application
9.3.5.2.3.
By Technique
9.3.5.2.4.
By Source
10.
South America Peripheral Blood Mononuclear Cells Market
Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1.
By
Product
10.2.2.
By
Application
10.2.3.
By
Technique
10.2.4.
By Source
10.2.5. By Country
10.3.
South America: Country Analysis
10.3.1. Brazil Peripheral
Blood Mononuclear Cells Market Outlook
10.3.1.1. Market Size &
Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share &
Forecast
10.3.1.2.1.
By Product
10.3.1.2.2.
By Application
10.3.1.2.3.
By Technique
10.3.1.2.4.
By Source
10.3.2. Argentina Peripheral
Blood Mononuclear Cells Market Outlook
10.3.2.1. Market Size &
Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share &
Forecast
10.3.2.2.1.
By Product
10.3.2.2.2.
By Application
10.3.2.2.3.
By Technique
10.3.2.2.4.
By Source
10.3.3. Colombia Peripheral
Blood Mononuclear Cells Market Outlook
10.3.3.1. Market Size &
Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share &
Forecast
10.3.3.2.1.
By Product
10.3.3.2.2.
By Application
10.3.3.2.3.
By Technique
10.3.3.2.4.
By Source
11.
Middle East and Africa Peripheral Blood Mononuclear Cells
Market Outlook
11.1.
Market Size & Forecast
11.1.1. By Value
11.2.
Market Share & Forecast
11.2.1.
By
Product
11.2.2.
By
Application
11.2.3.
By
Technique
11.2.4.
By Source
11.2.5. By Country
11.3.
MEA: Country Analysis
11.3.1. UAE Peripheral Blood
Mononuclear Cells Market Outlook
11.3.1.1. Market Size &
Forecast
11.3.1.1.1.
By Value
11.3.1.2. Market Share &
Forecast
11.3.1.2.1.
By Product
11.3.1.2.2.
By Application
11.3.1.2.3.
By Technique
11.3.1.2.4.
By Source
11.3.2. Saudi Arabia
Peripheral Blood Mononuclear Cells Market Outlook
11.3.2.1. Market Size &
Forecast
11.3.2.1.1.
By Value
11.3.2.2. Market Share &
Forecast
11.3.2.2.1.
By Product
11.3.2.2.2.
By Application
11.3.2.2.3.
By Technique
11.3.2.2.4.
By Source
11.3.3. South Africa
Peripheral Blood Mononuclear Cells Market Outlook
11.3.3.1. Market Size &
Forecast
11.3.3.1.1.
By Value
11.3.3.2. Market Share &
Forecast
11.3.3.2.1.
By Product
11.3.3.2.2.
By Application
11.3.3.2.3.
By Technique
11.3.3.2.4.
By Source
12. Market Dynamics
12.1.
Drivers
12.2.
Challenges
13. Market Trends &
Developments
14.
Clinical Trial Analysis
14.1.
Ongoing Clinical Trials
14.2.
Completed Clinical Trials
14.3.
Terminated Clinical Trials
14.4.
Breakdown of Pipeline, By Development Phase
14.5.
Breakdown of Pipeline, By Status
14.6.
Breakdown of Pipeline, By Study Type
14.7.
Breakdown of Pipeline, By Region
14.8.
Clinical Trials Heat Map
15. Competitive
Landscape
15.1.
Competitive Outlook
15.2.
Company Profiles
15.2.1. Charles River Laboratories
International, Inc.
15.2.2. Lonza Group AG
15.2.3. Corning Inc
15.2.4. Bio-Rad Laboratories
Inc
15.2.5. ABCAM
15.2.6. Biolegend Inc
15.2.7. ZEN-Bio Inc
15.2.8. DAPCEL, Inc.
15.2.9. Creative Bioarray
15.2.10.
iXCells Biotechnologies USA, LLC
15.2.11.
Miltenyi Biotec B.V. & CO. KG
15.2.12.
STEMCELL Technologies Inc.
15.2.13.
Precision Medicine Group, LLC.
15.2.14.
StemExpress, LLC
15.2.15.
RayBiotech Life, Inc.
15.2.16.
REPROCELL Inc.
15.2.17.
Cytologics LLC
15.2.18.
BioIVT LLC
15.2.19.
Biopredic International
15.2.20.
Cell Applications, Inc.
16. Strategic Recommendations
17. TechSci Research – Awards and Recognition
18. About Us & Disclaimer
Figure 1: Global
Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion),
2018-2028F
Figure 2: Global
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value,
2018-2028F
Figure 3: Global
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application Type,
By Value, 2018-2028F
Figure 4: Global
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By
Value, 2018-2028F
Figure 5: Global
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By
Value, 2018-2028F
Figure 6: Global
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Region, By Value,
2018-2028F
Figure 7: Global
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Company, By Value,
2022
Figure 8: Global
Peripheral Blood Mononuclear Cells Market (PBMCs) Map, By Product, Market Size
(USD Billion) & Growth Rate (%), 2022
Figure 9: Global
Peripheral Blood Mononuclear Cells Market (PBMCs) Map, By Application, Market
Size (USD Billion) & Growth Rate (%), 2022
Figure 10: Global
Peripheral Blood Mononuclear Cells Market (PBMCs) Map, By Technique, Market
Size (USD Billion) & Growth Rate (%), 2022
Figure 11: Global
Peripheral Blood Mononuclear Cells Market (PBMCs) Map, By Source, By Type,
Market Size (USD Billion) & Growth Rate (%), 2022
Figure 12: Global
Peripheral Blood Mononuclear Cells Market (PBMCs) Map, By Region, Market Size
(USD Billion) & Growth Rate (%), 2022
Figure 13: North
America Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD
Billion), 2018-2028F
Figure 14: North
America Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By
Value, 2018-2028F
Figure 15: North
America Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application,
By Value, 2018-2028F
Figure 16: North
America Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique,
By Value, 2018-2028F
Figure 17: North
America Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By
Type, By Value, 2018-2028F
Figure 18: North
America Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Country, By
Value, 2018-2028F
Figure 19: United
States Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD
Billion), 2018-2028F
Figure 20: United
States Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By
Value, 2018-2028F
Figure 21: United
States Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application,
By Value, 2018-2028F
Figure 22: United
States Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique,
By Value, 2018-2028F
Figure 23: United
States Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By
Type, By Value, 2018-2028F
Figure 24: Canada
Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion),
2018-2028F
Figure 25: Canada
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value,
2018-2028F
Figure 26: Canada
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By
Value, 2018-2028F
Figure 27: Canada
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By
Value, 2018-2028F
Figure 28: Canada
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By
Value, 2018-2028F
Figure 29: Mexico
Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion),
2018-2028F
Figure 30: Mexico
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value,
2018-2028F
Figure 31: Mexico
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By
Value, 2018-2028F
Figure 32: Mexico
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By
Value, 2018-2028F
Figure 33: Mexico
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By
Value, 2018-2028F
Figure 34: Europe
Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion),
2018-2028F
Figure 35: Europe
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value,
2018-2028F
Figure 36: Europe
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By
Value, 2018-2028F
Figure 37: Europe
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By
Value, 2018-2028F
Figure 38: Europe
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By
Value, 2018-2028F
Figure 39: Europe
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Country, By Value,
2018-2028F
Figure 40: Germany
Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion),
2018-2028F
Figure 41: Germany
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value,
2018-2028F
Figure 42: Germany
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By
Value, 2018-2028F
Figure 43: Germany
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By
Value, 2018-2028F
Figure 44: Germany
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By
Value, 2018-2028F
Figure 45: France
Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion),
2018-2028F
Figure 46: France
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value,
2018-2028F
Figure 47: France
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By
Value, 2018-2028F
Figure 48: France
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By
Value, 2018-2028F
Figure 49: France
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By
Value, 2018-2028F
Figure 50: United
Kingdom Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD
Billion), 2018-2028F
Figure 51: United
Kingdom Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By
Value, 2018-2028F
Figure 52: United
Kingdom Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By
Application, By Value, 2018-2028F
Figure 53: United
Kingdom Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique,
By Value, 2018-2028F
Figure 54: United
Kingdom Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By
Type, By Value, 2018-2028F
Figure 55: Italy
Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion),
2018-2028F
Figure 56: Italy
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value,
2018-2028F
Figure 57: Italy
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By
Value, 2018-2028F
Figure 58: Italy
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By
Value, 2018-2028F
Figure 59: Italy
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By
Value, 2018-2028F
Figure 60: Spain
Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion),
2018-2028F
Figure 61: Spain
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value,
2018-2028F
Figure 62: Spain
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By
Value, 2018-2028F
Figure 63: Spain
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By
Value, 2018-2028F
Figure 64: Spain
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By
Value, 2018-2028F
Figure 65: Asia
Pacific Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD
Billion), 2018-2028F
Figure 66: Asia
Pacific Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By
Value, 2018-2028F
Figure 67: Asia
Pacific Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application,
By Value, 2018-2028F
Figure 68: Asia
Pacific Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique,
By Value, 2018-2028F
Figure 69: Asia
Pacific Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By
Type, By Value, 2018-2028F
Figure 70: Asia
Pacific Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Country, By
Value, 2018-2028F
Figure 71: China
Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion),
2018-2028F
Figure 72: China
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value,
2018-2028F
Figure 73: China
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By
Value, 2018-2028F
Figure 74: China
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By
Value, 2018-2028F
Figure 75: China
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By
Value, 2018-2028F
Figure 76: Japan
Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion),
2018-2028F
Figure 77: Japan
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value,
2018-2028F
Figure 78: Japan
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By
Value, 2018-2028F
Figure 79: Japan
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By
Value, 2018-2028F
Figure 80: Japan
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By
Value, 2018-2028F
Figure 81: India
Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion),
2018-2028F
Figure 82: India
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value,
2018-2028F
Figure 83: India
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value,
2018-2028F
Figure 84: India
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By
Value, 2018-2028F
Figure 85: India
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By
Value, 2018-2028F
Figure 86: South
Korea Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD
Billion), 2018-2028F
Figure 87: South
Korea Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By
Value, 2018-2028F
Figure 88: South
Korea Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application,
By Value, 2018-2028F
Figure 89: South
Korea Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By
Value, 2018-2028F
Figure 90: South
Korea Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By
Type, By Value, 2018-2028F
Figure 91: Australia
Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion),
2018-2028F
Figure 92: Australia
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value,
2018-2028F
Figure 93: Australia
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By
Value, 2018-2028F
Figure 94: Australia
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By
Value, 2018-2028F
Figure 95: Australia
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By
Value, 2018-2028F
Figure 96: Singapore
Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion),
2018-2028F
Figure 97: Singapore
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value,
2018-2028F
Figure 98: Singapore
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By
Value, 2018-2028F
Figure 99: Singapore
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By
Value, 2018-2028F
Figure 100: Singapore
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By
Value, 2018-2028F
Figure 101: Middle
East & Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By
Value (USD Billion), 2018-2028F
Figure 102: Middle
East & Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By
Product, By Value, 2018-2028F
Figure 103: Middle
East & Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By
Application, By Value, 2018-2028F
Figure 104: Middle
East & Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By
Technique, By Value, 2018-2028F
Figure 105: Middle
East & Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By
Source, By Type, By Value, 2018-2028F
Figure 106: Middle
East & Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By
Country, By Value, 2018-2028F
Figure 107: UAE
Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion),
2018-2028F
Figure 108: UAE
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value,
2018-2028F
Figure 109: UAE
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By
Value, 2018-2028F
Figure 110: UAE
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By
Value, 2018-2028F
Figure 111: UAE
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By
Value, 2018-2028F
Figure 112: Saudi
Arabia Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD
Billion), 2018-2028F
Figure 113: Saudi
Arabia Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By
Value, 2018-2028F
Figure 114: Saudi
Arabia Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application,
By Value, 2018-2028F
Figure 115: Saudi
Arabia Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique,
By Value, 2018-2028F
Figure 116: Saudi
Arabia Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By
Type, By Value, 2018-2028F
Figure 117: South
Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD
Billion), 2018-2028F
Figure 118: South
Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By
Value, 2018-2028F
Figure 119: South
Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application,
By Value, 2018-2028F
Figure 120: South
Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique,
By Value, 2018-2028F
Figure 121: South
Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By
Type, By Value, 2018-2028F
Figure 122: South
America Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD
Billion), 2018-2028F
Figure 123: South
America Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By
Value, 2018-2028F
Figure 124: South
America Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By
Application, By Value, 2018-2028F
Figure 125: South
America Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique,
By Value, 2018-2028F
Figure 126: South
America Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By
Type, By Value, 2018-2028F
Figure 127: South
America Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Country, By
Value, 2018-2028F
Figure 128: Brazil
Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion),
2018-2028F
Figure 129: Brazil
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value,
2018-2028F
Figure 130: Brazil
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By
Value, 2018-2028F
Figure 131: Brazil
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By
Value, 2018-2028F
Figure 132: Brazil
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By
Value, 2018-2028F
Figure 133: Argentina
Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion),
2018-2028F
Figure 134: Argentina
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value,
2018-2028F
Figure 135: Argentina
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By
Value, 2018-2028F
Figure 136: Argentina
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By
Value, 2018-2028F
Figure 137: Argentina
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By
Value, 2018-2028F
Figure 138: Colombia
Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion),
2018-2028F
Figure 139: Colombia
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value,
2018-2028F
Figure 140: Colombia
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By
Value, 2018-2028F
Figure 141: Colombia
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By
Value, 2018-2028F
Figure 142: Colombia
Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By
Value, 2018-2028F
Figure 143: Global
Percentage of Cell and Gene Therapy Clinical Trials as of 2019, Divided by
Clinical Trial Phase
Figure 144: Peripheral
Blood Mononuclear Cells: Breakdown of Pipeline, By Development Phase, 1992-2023
Figure 145: Peripheral
Blood Mononuclear Cells: Breakdown of Pipeline, By Status, 1992-2023
Figure 146: Peripheral
Blood Mononuclear Cells: Breakdown of Pipeline, By Study Type, 1992-2023
Figure 147: Peripheral
Blood Mononuclear Cells: Breakdown of Pipeline, By Region, 1992-2023
Figure 148: Peripheral
Blood Mononuclear Cells: Breakdown of Pipeline, By Year, 2017-2023
Figure 149: Peripheral
Blood Mononuclear Cells: Clinical Trials Heat Map
Table 1: Global Cancer Statistics, 2020
Table 2: Total Number of New Cancer Cases and
Deaths Reported Globally, By Type, 2020
Table 3: North America Cancer Statistics, 2020
Table 4: Total Number of New Cancer Cases and
Deaths Reported in North America, By Type, 2020
Table 5: Europe Cancer Statistics, 2020
Table 6: Total Number of New Cancer Cases and
Deaths Reported in Europe, By Type, 2020
Table 7: Asia Pacific Cancer Statistics, 2020
Table 8: Total Number of New Cancer Cases and
Deaths Reported in Asia Pacific, By Type, 2020
Table 9: Middle East & Africa Cancer
Statistics, 2020
Table 10: Total Number of New Cancer Cases and
Deaths Reported in Middle East & Africa, By Type, 2020
Table 11: South America Cancer Statistics, 2020
Table 12: Total Number of New Cancer Cases and
Deaths Reported in South America, By Type, 2020
Table 13: Pricing Analysis of PBMC Products
Table 14: Clinical Trial Analysis